memantine at the higher doses (> 0.051 mg/kg/day) produced dose-dependent negative behavioral, Objectives To determine the toxicity window for the continuous intrathecal administration of dextrorphan, dexmotor, and histopathologic changes as indicated by a series of nonparametric statistical analyses. The minimal tromethorphan, and memantine via an implanted delivery pump. toxic doses were dextrorphan dose 3, dextromethorphan dose 1 and memantine dose 1. This study suggests Materials and Methods Using 48 sheep with programmable continuous intrathecal infusion systems we deterthat continuous intrathecal infusion of dextrorphan, dextromethorphan, and memantine via an implantable mined the behavioral, motor, neurological, and histopathological changes produced by a 43-day conpump system can cause significant toxicities at the higher doses studied. Ⅲ tinuous infusion study of dextrorphan, dextromethorphan, and memantine dissolved in 0.9% NaCl. Daily doses of each N-methyl-D-aspartate (NMDA) antago-KEY WORDS: continuous, dextromethorphan, dextrornist were 0.013, 0.051, 0.203, 0.510, 0.811, and 2.533 mg/ phan, infusion, intrathecal, memantine, sheep. kg/day, flow rates ranged from 13.25 ml/day to 0.051 ml/day at a concentration of 10 mg/ml. Control animals received saline in the range of 7.9985 ml/day to 1 ml/ N-methyl-D-aspartate (NMDA) receptors in the dor- 
eral inflammation (6) , formalin-induced pain behavmethylmorphinan-D-tartrate] are dextrorotary morphinans. Dextromethorphan and dextrorphan are ior (7), tail ischemia (8) , hyperalgesia induced by painful mononeuropathy (9,10), allodynia (11) , and widely used non-narcotic antitussives (29) and more recently found to possess anticonvulsant properties mechanical hyperalgesia (12). Dubner suggested that the dorsal horn nociceptive neurons mediated in many seizure models (30, 31) . Memantine [1-amino-3, 5-dimethyladamantane], an aminoadainanhyperalgesia following nerve injury or tissue inflammation which involved the release of excitatory tane derivative of the same subclass of NMDA receptors as dextromethorphan and dextrorphan, is amino acids and their action at the NMDA receptor sites (12). This means that NMDA antagonists can among the few NMDA receptor antagonists used clinically for many years for the treatment of Parkinbenefit clinical applications as analgesics in the future. The NMDA antagonists dextrorphan and memson's disease (32) (33) (34) (35) . These ligands are well tolerated (oral and intravenous administration), and their antine produce analgesia in neuropathic pain animal models (4,13). Tal et al. found the analgesic activity safety, compared with that of MK-801 or phencyclidine, may be due to their rapid-response kinetics of dextrorphan to be temporary and suggested frequent dosing or continuous infusion. However, (2, 22, 32, 36, 37) . Memantine also shows promise in the treatment of dementia (38) (39) (40) , spasticity (41) there are no data on the safety, side-effect profile, or toxicity of long-term administration in animals or and seizures (31) . man (14) . To establish toxicity levels of continuous intrathecal administration of the NMDA antagonists dextrorphan, dextromethorphan, and memantine,
MATERIALS AND METHODS sheep implanted with intrathecal delivery systems
After approval by the Institutional Animal Care and were studied prior to preclinical studies.
Use partment of Veterinary Sciences (Bastrop, TX) in Because of the concern over the side effects of instrict accordance to the Guide for the Care and trathecal opioids, especially delayed respiratory deUse of Laboratory Animals published by National pression, other classes of drugs are under Research Council (42). The 48, one-and two-yearexamination for spinal analgesia (17) . With few exold Rambouillet/Suffolk-cross sheep used in this ceptions, these drugs lack animal neurotoxicity data study weighed between 22 and 58 kg. The male (18-21). The behavioral and histopathologic effects sheep (N ‫ס‬ 39) weighed an average of 43.65 kg of long-term continuous intrathecal infusion of dexand the female (N ‫ס‬ 2) weighed an average of 36.0 trorphan, dextromethorphan, and memantine need kg. The sizes of the groups were originally two sheep examination (14) . We therefore undertook the study per dose for each of the three agents. However, of the behavioral, neurologic, and histologic effects some sheep at the same dose were equivocal and of chronic (up to 43 days) intrathecal infusion of we added a third sheep to add finer detail to the these drugs in the sheep model. gradation of changes in some of the groups. Also, Activation of the NMDA type of excitatory amino dose level 5 of memantine was not administered to acid receptors increases the Ca2 ‫ם‬ conductance of any sheep due to the toxic effects already evident the cation channel due to extracellular accumulaat dose level 4. tion of glutamate (22) (23) (24) . The excessive levels of glutamate or related neurotransmitters are associDrugs ated with neuroneal cell death in hypoxic-ischemic brain injury (1, 25) , epilepsy, trauma (26) , and sevOur lab obtained dextromethorphan from Sigma Chemical Co. (St. Louis, MO) and purchased dextroreral neurodegenerative diseases such as Huntington's disease, Parkinson's disease (27) , and acquired phan and memantine from Research Biochemicals International (Natick, MA). The agents were preimmunodeficiency syndrome dementia (28) .
The open-channel (use-dependent) NMDA subpared as the following salts: dextrorphan tartrate (10 mg/ml, pH 3.3), dextromethorphan hydrobromide class glutamate receptor antagonist dextromethorphan [(‫-3-)ם‬methoxy-N-methylmorphinan] and its (10 mg/ml, pH 5.96), and memantine HCl (10 mg/ ml, pH 5.90). The vehicle utilized was 0.9% NaCl active metabolite dextrorphan [(‫-3-)ם‬hydroxy-N-(pH 5.7). The agents were individually prepared and sterilized by passing solutions through 0.22 m Millipore filters (Bedford, MA) into sterile vials in a sterile hood (Nuaire Class II Type A/B3 cabinet, Plymouth, MN) and stored at room temperature.
Our lab did not independently analyze the agents. The manufacturer lists the purities to be: dextrorphan > 99%, dextromethorphan > 99%, memantine > 95%. The absence of other manufacturer products was determined using high-performance liquid chromatography. 2). A dose concentration of 10 mg/ml was chosen into the Tuohy needle and advancing the catheter because it would be a clinically used concentration. cephalad into the subarachnoid space provides drug This concentration is high enough to be useful for delivery to the approximate level of T-13/L-1 (cathean implanted pump in humans and easy to use for ter is threaded approximately 17 cm cephalad). A calculations, and is a concentration where the drug 2-0 silk suture secures the metal connector and the pump connector assembly which link the intrathecal catheter to the pump (Medtronic Synchromed tunneled to that area and connected to the pump (Fig. 1) . A 2-0 silk suture secured the pump to the 0 Animal standing, eating, drinking, and ruminating, with normal respiratory and heart rates. Sheep able muscle fascia. At the time of surgery, and for the to rise and ambulate without any difficulty.
week following surgery, the pumps delivered 1 ml elicit any response.
After 1-week postoperative recovery, studies is stable in solution. The doses of the NMDA antagogross anatomic and histopathologic changes. The different doses in these studies were obtained by nists were initially chosen in this toxicologic assessment to represent a four-fold increase per dose as changing the flow rates (0.051-13.25 ml/day) and the concentrations of drug remained constant (10 the doses escalated (levels 1, 2, 3, 4). Dose 3.5 was added to delineate moderate changes (neurologic, mg/ml). These studies were then followed by a double-blinded study in which the experimenters had histologic) between levels 3 and 4. We also added level 5 as a supramaximal dose (three times higher no knowledge of the 21 different treatment conditions which were actually six dosing levels plus conthan dose 4) to see maximal neurologic changes. The high flow rate of the control animal receiving trols. In the blinded studies the flow rate remained constant and the drug concentrations varied so the 7.9985 ml/day was administered to demonstrate that behavioral changes were caused by the toxic effects investigators would be unaware of the dose being administered. A flow rate of 1.636 ml/day was choof the drugs and not by the added fluid pressure of larger injection volume at higher known doses.
sen for the blinded studies because it allowed for the different doses to be formulated without the Prior to the study, previously published literature was reviewed and criteria were developed for the drug falling out of solution at the higher doses. behavioral, neurologic and histopathologic changes ( Table 1 and Table 2 ). However, since there were Histopathology not any reported data for long-term continuous infusion of these NMDA antagonists, known doses were Animals were euthanized on day 43 or when the sheep became paraplegic and underwent necropadministered to establish dose-related behavioral, sies. Immediately after each animal was euthanized, study, three animals had questionable patency of the intrathecal catheters; one animal had a neurologic we collected approximately 2-3 ml of CSF from the L7/S1 intravertebral space for fluid analysis and for deficit caused by intraoperative trauma; another animal developed a seroma over the area of the imbacteriologic cultures to assure that the changes seen upon histopathologic examination were due planted pump; and catheters in two animals migrated into the epidural space. The mean duration to drug-related effects and not bacteriologic considerations.
of implantation was 29.1 days ‫ע(‬ 16.6) for all sheep receiving study drugs. All the control sheep survived A laminectomy was performed from S-1 cephalad to C-1, and the location of the catheter insertion for the entire 43 days, which was significantly different from the animals that received dextrorphan, and termination site documented. Removal of the entire brain and spinal cord allowed for gross examidextromethorphan, or memantine. The results did not differ between male (39 sheep) and female (2 nation to detect significant lesions. Blocks of tissue from the following CNS areas were embedded in sheep) animals, and their data were merged for subsequent analysis. paraffin wax for histopathologic examination: cervical, thoracic, and lumbosacral segments of the spinal cord and the olfactory; frontal lobe; posterior cinguPhysiologic Effects late gyrus; amygdala; hippocampus; retrosplenium cortex; cerebellum; pons; and medulla regions of
In all of the studies, there was no deviation from the brain. The spinal cord, brain, and samples of normal values with respect to body temperature, the liver, spleen, heart, kidney, and intestines were blood pressure, heart rate, or blood chemistries. fixed for two weeks in 10% neutral formalin. SecBacterial cultures taken of the saline infusate and tions were cut transversely at a thickness of 4 m to CSF at sacrifice showed no growth after seven days 5 m, deparaffinized, then stained by conventional of observation. methods that included hematoxylin and eosin and Luxol fast blue-Holmes' silver nitrate stains, and examined for toxic reaction. In the double-blinded
Behavioral and Motor Observations
The behavioral/motor changes and the number of studies, evaluation of the gross and histopathologic changes was performed by a pathologist blinded to days the animal received the antagonists are summarized in Table 2 . The saline-infused animals did not the different drugs and their doses.
exhibit any behavioral or motor changes. All motor deficits affected the hind limbs only. The sheep that Statistical Analysis developed hind limb paralysis were unresponsive to noxious cutaneous stimulation, however, bowel Comparisons across two groups (ie, low dose vs. high dose) were analyzed using the nonparametric and bladder control were normal. Micturition and defecation in these paraplegic animals was moniMann-Whitney U statistic (U). Comparisons across three or more groups (ie, dextrorphan vs. dextrotored by assisting the animal in rising and supporting them in the standing position for a period of 5 min. methorphan vs. memantine) were analyzed using the nonparametric Kruskal-Wallis statistic (H). SysSheep normally urinate and defecate after rising from the prone position. We speculate that the anitat 5.1 for DOS performed the analysis. mals' autonomic systems were still intact (bowel, bladder) while the somatic systems (neuromuscular and sensory) were affected by the histopathologic RESULTS changes (inflammation, necrosis, etc.). This is sometimes seen in humans with spinal cord compression All 48 sheep randomly received continuous intrathecal administration of dextrorphan, dextroinjury. Responses to high doses of all three drugs differed significantly from responses to dose level methorphan, or memantine via subcutaneous, programmable continuous-infusion pumps (Medtronic 2 and lower in regard to the behavior and motor grade and the number of days the animal received Synchromed, pump models 8615 and 8617). Of these 48 animals, 41 were actually used in the study the test agents (U ‫ס‬ 24, p 0.001 and U ‫ס‬ 240, p 0.001 respectively; Mann-Whitney U statistic). The groups. Of the seven animals excluded from the neurologic symptoms the sheep developed typically began with the animal biting the area of the catheter tip location, progressing to stiffness in the rear legs, limping on one rear leg, loss of righting reflex in the effected leg, dragging of the leg, guarded posture, difficulty rising, and paraplegia. These symptoms appeared as early as the first day after the animal was started on drug or as late as day 36. However, these symptoms varied in severity and extent of toxicity based on the dose level and the drug the animal received. Only one animal (dextrorphan dose 3) recovered from a drug-induced neuroneal deficit. This sheep lost the righting reflex in the right rear leg on day 6 of the drug study, which continued until day 9 when the sheep began to regain the righting reflex and continued to improve until normal behavior returned on day 13.
The threshold doses for neurotoxicity are dextrorphan dose 3, dextromethorphan dose 1, and memantine dose 1. Behavior and motor grades statistically control group (H ‫ס‬ 9.33, p < 0.05, 3df, Kruskal-Wallis statistic). Dextromethorphan produced the highest behavior and motor grades and dextrorphan the lowest; the control animals exhibited no change in behavior or motor activity.
Gross Post-mortem Observations
Gross examination of the spinal cord confirmed the catheter insertion site at L7-S1 (Fig. 2) and catheter termination sites (Fig. 3) ranging from L-6 to T-10 with the majority between T-13 and L-2. The course of each catheter varied (dorsal > ventral > right lateral > left ventral > right dorsal lateral > left lateral ‫ס‬ right ventral) and appeared to have no effect on any of the gross changes observed. In contrast, the presence of gross lesions in the spinal cord were consistently associated with the catheter tip location.
Histopathologic Assessment
A summary of the spinal histopathology for all the sheep in these studies are presented in Table 2 . At high dosing levels all of the agents studied statistically differed from dose level 2 and lower in regard to the presence of inflammatory cells and necrosis (U ‫ס‬ 3 1, p < 0.001 and U ‫ס‬ 23, p < 0.001, respec- 
5df). Purulent inflammation and infiltration
The administration of intrathecal or epidural morphine for chronic pain states is widespread and wellof neutrophils, macrophages, and an occasional giant cell characterized the necrosis. Axonal established (15,18). However, unpredicted side effects such as ventilatory depression, itching, and changes included axonal swelling and axonal loss. High CSF values of total protein were associated urinary retention have been reported (16) and the use of spinally administered morphine has been acwith spinal lesions in all but one sheep. One of the control animals had a total protein level of 284 mg/ companied by reports of tolerance (43) . Common clinical practice including our experience and that dl. However, histologic examination of this animal did not reveal any microscopic lesions. The regions of others (44) found that morphine tolerance could develop to a point where intrathecal doses of 50 of the brain that were examined did not reveal any significant microscopic lesions. Histologic evaluamg/day were ineffective in controlling pain. Additionally, some neuropathic pain syndromes may be tion of the various organs did not reveal any drugrelated changes. The histologic changes were doseunresponsive to morphine (15,16). Therefore, it is believed by many researchers that morphine may dependent with the exception of four animals. One sheep that had received memantine level 2 showed not be the drug of choice for intrathecal administration (18). In response to the need for developing no behavioral, motor, or neurologic symptoms. Gross post-mortem examination revealed a lesion new agents for spinal administration in the clinical setting (45) , this preliminary investigation of the measuring 1 cm † 0.5 cm at the site of catheter termination. Histologic exam of this sheep revealed toxic effects of dextrorphan, dextromethorphan, and memantine was conducted. Recent studies in moderate to severe changes. Conversely, the other animal receiving the same dose exhibited mild clinirats showed these agents to be promising in the treatment of hyperalgesia and allodynia (11) . These cal symptoms yet had no histopathologic damage to the spinal cord. One of the animals that received NMDA antagonists have been in use clinically for many years, dextrorphan and dextromethorphan as memantine level 3 revealed severe behavioral and motor effects and had to be euthanized on day 10.
antitussives and more recently as anticonvulsants in the treatment of epilepsy (46) and memantine for Gross examination at necropsy revealed a ventral lesion at L1-T13 with purulent inflammation, discolthe treatment of Parkinson's disease (34) and dementia (39,47). Presently, there are no data on the safety, oration, and necrosis. The sheep that had dextromethorphan at dose level 2 exhibited moderate side-effect profiles, or toxicity of long-term intrathecal administration of dextrorphan, dextromethorbehavioral changes and appeared grossly normal at necropsy. However, upon sectioning the formalinphan, or memantine in animals or man (14) . Previous researchers expressed concern over the fixed cord, areas of discoloration and slight swelling were associated with the catheter termination site.
use of experimental agents and clinically approved agents administered via a different route (for examOne of the sheep that received dextrorphan level 3 recovered from moderate behavior changes and ple, approved for oral administration but delivered intrathecally) without behavioral, toxicologic, and appeared grossly normal at necropsy. Histopathologic examination of this animal revealed moderate histopathologic data from animal studies (14, 21, 22, 48, 49) . It has been proposed that the neuand severe histologic changes. The histopathologic changes noted in these four sheep were similar to rotoxic potential of spinally administered drugs may not be adequately detected when morphologic analthose seen in sheep that were given higher doses of the drugs. No significant gross anatomic changes ysis does not include functional studies (20). Therefore, the lack of behavioral changes alone is not were noted in control animals. However, upon histopathologic examination, three of the seven control sufficient to eliminate the possibilities of a drug having neurotoxic effects (21). Also, it is feasible animals showed a very mild catheter reaction consisting of a mild fibrosis around the catheter. The that toxicity can be present in the absence of neurologic symptoms. For these reasons, in the present occurrence of intrathecal fibrous reaction did not differ between the dose levels (H ‫ס‬ 4.75, > 0.05, study, histopathologic changes as well as neurologic, motor, and behavioral changes were examined. 5 d.f.).
The sheep was chosen as the animal model beinfusion volume range in these studies ranged between 0.051 ml/day and 13.25 ml/day. However, in cause its neural axis is similar to the human's in relation to spinal cord length, CSF volume, CSF prothe blinded studies, all the volumes remained the same (1.636 ml/day) and the concentration varied. duction, and body weight; thus providing in the study animal a body cavity and anatomic spaces
Comparing the different volumes administered within a drug and within one dose rate, the higher close to what would be encountered in a human patient (50) . In addition, the volume of the spinal volumes of injectate did not statistically increase the incidence of pathology. CSF compartment in the sheep is large enough to allow some dilution of the test agent and therefore Dextrorphan, the more potent active metabolite of dextromethorphan (63), appears to be the least more closely approximate lumbar intrathecal administration in the human (51) . Previous studies of local toxic of the study drugs at dose levels 3 and lower. However, one animal that received dextrorphan anesthetics in sheep indicated that this animal model probably has the same milligram-per-kilogram dose level 3 displayed moderate behavioral changes and severe to moderate histopathologic changes. dose requirements as humans do (52) . Furthermore, utilizing the sheep, our surgical protocol is analoTwo other sheep receiving the same dose exhibited no behavioral or motor changes and minimal to no gous to the surgical protocol used in humans (semipercutaneous placement of the intrathecal catheter), histopathologic change. Conversely, dextromethorphan was clearly the which is very difficult in other large animal models like the dog in which a mini-laminotomy must be most irritating to the spinal cord tissue. Toxic reaction was present at all dosing levels upon histologic performed (53) . The sheep has been routinely used by investigators to study the effects of various subexamination with the exception of two animals; tissue samples from two sheep dosed at levels 1 and stances administered into the subarachnoid space (54) . Others have investigated the neurotoxicity 2 revealed no histologic changes. Additionally, all dose levels of dextromethorphan exhibited behavof intrathecal local anesthetics (55), enkephalinase inhibitors (51), pharmacokinetic distribution of ioral and neurologic changes (with the exception of the same two animals that did not show such opiates given epidurally, intrathecally, or intraventricularly (56-59), and antinociception after epichanges). Slightly less toxic than dextromethorphan, memdural administration of clonidine (60, 61) .
Like Rawal et al. we noted a dramatic difference in antine at dose level 1 presented no behavioral, motor, or neurologic changes. However, all animals the behavioral responses between animals receiving similar volumes of saline or test drug (18). The spinal that received the drug at dose level 3 and above displayed behavioral, motor, neurologic, and histoadministration of dextrorphan, dextromethorphan, and memantine showed dose-dependent onset and logic changes, except for one sheep at dose level 3 that showed no such changes. duration of behavioral, motor, and neurologic changes. These changes were so sensitive that we No significant behavioral, motor, neurologic, or gross anatomic changes were noted in control anirepeatedly noticed biting of the area associated with the catheter tip location as an early sign of toxicity. mals. Histopathologic examination revealed three of the six control animals to have a minimal catheter This behavior was also noted by Atchison et al. in a dog that received 30 mg of intrathecal morphine.
reaction consisting of a mild fibrosis around the catheter. This reaction has been noted in other animal This animal went into convulsions 15 min after exhibiting this behavior, and died shortly thereafter models and may be unavoidable to some extent due to the presence of the catheter and simple mechani-(62). Our findings and those by others (11, 14) have demonstrated that high doses of these agents procal irritation (44, 64) . Our study presented a general correlation between degree of behavioral, motor, duce obvious motor deficits.
There was no correlation between weight and and neurologic change and the degree of histopathologic change. However, we also showed that neuroclinical symptoms or histopathologic results within the dose groups. In the known dose studies where toxic effects can be present without an animal showing any clinical symptoms. The severe neurothe concentration of drug remained the same(10 mg/ml), the flow rates did vary between sheep detoxic effects of the higher doses of the NMDA antagonists studied in this investigation and the case pending on dose and the weight of the animal. The 
